Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Preoperative differentiation of primary central nervous system lymphoma (PCNSL) from glioblastoma (GBM) is important to guide neurosurgical decision‐making.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To validate the generalization ability of radiomics models based on multiparametric‐MRI (MP‐MRI) for differentiating PCNSL from GBM.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Population</h3><p>In all, 240 patients with GBM (<i>n</i> = 129) or PCNSL (<i>n</i> = 111). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>3.0T scanners (two vendors). Sequences: fluid‐attenuation inversion recovery, diffusion‐weighted imaging (DWI), and contrast‐enhanced T<sub>1</sub>‐weighted imaging (CE‐T<sub>1</sub>WI). Apparent diffusion coefficients (ADCs) were derived from DWI. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Cross‐vendor and mixed‐vendor validation were conducted. In cross‐vendor validation, the training set was 149 patients' data from vendor 1, and test set was 91 patients' data from vendor 2. In mixed‐vendor validation, a training set was 80% of data from both vendors, and the test set remained at 20% of data. Single and multisequence radiomics models were built. The diagnoses by radiologists with 5, 10, and 20 years' experience were obtained. The integrated models were built combining the diagnoses by the best‐performing radiomics model and each radiologist. Model performance was validated in the test set using area under the ROC curve (AUC). Histological results were used as the reference standard.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>DeLong test: differences between AUCs. <i>U</i>‐test: differences of numerical variables. Fisher's exact test: differences of categorical variables. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>In cross‐vendor and mixed‐vendor validation, the combination of CE‐T<sub>1</sub>WI and ADC produced the best‐performing radiomics model, with AUC of 0.943 vs. 0.935, <i>P</i> = 0.854. The integrated models had higher AUCs than radiologists, with 5 (0.975 vs. 0.891, <i>P</i> = 0.002 and 0.995 vs. 0.885, <i>P</i> = 0.007), 10 (0.975 vs. 0.913, <i>P</i> = 0.029 and 0.995 vs. 0.900, <i>P</i> = 0.030), and 20 (0.975 vs. 0.945, <i>P</i> = 0.179 and 0.995 vs. 0.923, <i>P</i> = 0.046) years' experiences. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>Radiomics for differentiating PCNSL from GBM was generalizable. The model combining MP‐MRI and radiologists' diagnoses had superior performance compared to the radiologists alone.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>4</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>2</p></section>

Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach

Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach

Molecular Subtyping of Diffuse Gliomas Using Magnetic Resonance Imaging: Comparison and Correlation Between Radiomics and Deep Learning.

Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques

Radiomics-Based Machine Learning in Differentiation Between Primary Central Nervous System Lymphoma And Solitary Brain Metastasis

Machine Learning-Based Analysis of Magnetic Resonance Radiomics for the Classification of Gliosarcoma and Glioblastoma

Differentiation Between Primary Central Nervous System Lymphoma and Atypical Glioblastoma Based on MRI Morphological Feature and Signal Intensity Ratio: A Retrospective Multicenter Study

Multiparametric‐MRI ‐Based Radiomics Model for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma: Development and Cross‐Vendor Validation

Differentiation of Supratentorial Single Brain Metastasis and Glioblastoma by Using Peri-Enhancing Oedema Region–derived Radiomic Features and Multiple Classifiers

Machine Learning and Deep Learning CT-Based Models for Predicting the Primary Central Nervous System Lymphoma and Glioma Types: A Multicenter Retrospective Study

Radiomics-Based Machine Learning Technology Enables Better Differentiation Between Glioblastoma and Anaplastic Oligodendroglioma.

Glioblastoma and primary central nervous system lymphoma: differentiation using MRI derived first-order texture analysis – a machine learning study

Machine learning–based multiparametric magnetic resonance imaging radiomics model for distinguishing central neurocytoma from glioma of lateral ventricle

Magnetic resonance radiomics differentiates gliosarcoma from glioblastoma multiforme

Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient

Machine learning based differentiation of glioblastoma from brain metastasis using MRI derived radiomics

Radiomics for differentiation of gliomas from primary central nervous system lymphomas: a systematic review and meta-analysis

Classifying primary central nervous system lymphoma from glioblastoma using deep learning and radiomics based machine learning approach - a systematic review and meta-analysis

Primary Central Nervous System Lymphoma and Glioblastoma Differentiation Based on Conventional Magnetic Resonance Imaging by High-Throughput SIFT Features

Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation

MRI-Based Machine Learning for Prediction of Clinical Outcomes in Primary Central Nervous System Lymphoma